These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26200600)

  • 1. Catalytic bioscavengers in nerve agent poisoning: A promising approach?
    Worek F; Thiermann H; Wille T
    Toxicol Lett; 2016 Feb; 244():143-148. PubMed ID: 26200600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In search of a catalytic bioscavenger for the prophylaxis of nerve agent toxicity.
    diTargiani RC; Chandrasekaran L; Belinskaya T; Saxena A
    Chem Biol Interact; 2010 Sep; 187(1-3):349-54. PubMed ID: 20176006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered Recombinant PON1-OPH Fusion Hybrids: Potentially Effective Catalytic Bioscavengers against Organophosphorus Nerve Agent Analogs.
    Lee N; Yun H; Lee C; Lee Y; Kim E; Kim S; Jeon H; Yu C; Rho J
    J Microbiol Biotechnol; 2021 Jan; 31(1):144-153. PubMed ID: 33144547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in the development of enzyme-based nerve agent bioscavengers.
    Nachon F; Brazzolotto X; Trovaslet M; Masson P
    Chem Biol Interact; 2013 Dec; 206(3):536-44. PubMed ID: 23811386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalytic efficiencies of directly evolved phosphotriesterase variants with structurally different organophosphorus compounds in vitro.
    Goldsmith M; Eckstein S; Ashani Y; Greisen P; Leader H; Sussman JL; Aggarwal N; Ovchinnikov S; Tawfik DS; Baker D; Thiermann H; Worek F
    Arch Toxicol; 2016 Nov; 90(11):2711-2724. PubMed ID: 26612364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of catalytic bioscavengers against organophosphorus agents.
    Masson P; Lushchekina SV
    Chem Biol Interact; 2016 Nov; 259(Pt B):319-326. PubMed ID: 26899146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A catalytic bioscavenger with improved stability and reduced susceptibility to oxidation for treatment of acute poisoning with neurotoxic organophosphorus compounds.
    Job L; Köhler A; Escher B; Worek F; Skerra A
    Toxicol Lett; 2020 Mar; 321():138-145. PubMed ID: 31891759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organophosphate hydrolases as catalytic bioscavengers of organophosphorus nerve agents.
    Trovaslet-Leroy M; Musilova L; Renault F; Brazzolotto X; Misik J; Novotny L; Froment MT; Gillon E; Loiodice M; Verdier L; Masson P; Rochu D; Jun D; Nachon F
    Toxicol Lett; 2011 Sep; 206(1):14-23. PubMed ID: 21683774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostics and treatment of nerve agent poisoning-current status and future developments.
    Amend N; Niessen KV; Seeger T; Wille T; Worek F; Thiermann H
    Ann N Y Acad Sci; 2020 Nov; 1479(1):13-28. PubMed ID: 32198755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the benefit of the bispyridinium compound MB327 for the antidotal treatment of nerve agent-poisoned mice.
    Kassa J; Pohanka M; Timperley CM; Bird M; Green AC; Tattersall JE
    Toxicol Mech Methods; 2016 Jun; 26(5):334-9. PubMed ID: 27097774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro.
    Worek F; Seeger T; Goldsmith M; Ashani Y; Leader H; Sussman JS; Tawfik D; Thiermann H; Wille T
    Arch Toxicol; 2014 Jun; 88(6):1257-66. PubMed ID: 24477626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioscavenger is effective as a delayed therapeutic intervention following percutaneous VX poisoning in the guinea-pig.
    Mann TM; Price ME; Whitmore CL; Perrott RL; Laws TR; McColm RR; Emery ER; Tattersall JEH; Green AC; Rice H
    Toxicol Lett; 2018 Sep; 293():198-206. PubMed ID: 29183815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Engineering of catalytic bioscavengers of organophosphorus compounds].
    Masson P; Nachon F; Rochu D
    Bull Acad Natl Med; 2007 Jan; 191(1):95-111; discussion 112. PubMed ID: 17645110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential role of bioscavenger in the medical management of nerve-agent poisoned casualties.
    Rice H; Mann TM; Armstrong SJ; Price ME; Green AC; Tattersall JEH
    Chem Biol Interact; 2016 Nov; 259(Pt B):175-181. PubMed ID: 27144491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug development for the management of organophosphorus poisoning.
    Elsinghorst PW; Worek F; Thiermann H; Wille T
    Expert Opin Drug Discov; 2013 Dec; 8(12):1467-77. PubMed ID: 24125474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human paraoxonase: a promising approach for pre-treatment and therapy of organophosphorus poisoning.
    Rochu D; Chabrière E; Masson P
    Toxicology; 2007 Apr; 233(1-3):47-59. PubMed ID: 17007987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalytic bioscavengers as countermeasures against organophosphate nerve agents.
    Goldsmith M; Ashani Y
    Chem Biol Interact; 2018 Aug; 292():50-64. PubMed ID: 29990481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Organophosphorus poisoning: Towards enzymatic treatments].
    Jacquet P; Poirier L; Daudé D; Chabrière E
    Ann Pharm Fr; 2019 Sep; 77(5):349-362. PubMed ID: 31253354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalytic bioscavengers against toxic esters, an alternative approach for prophylaxis and treatments of poisonings.
    Masson P; Rochu D
    Acta Naturae; 2009 Apr; 1(1):68-79. PubMed ID: 22649587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single treatment of VX poisoned guinea pigs with the phosphotriesterase mutant C23AL: Intraosseous versus intravenous injection.
    Wille T; Neumaier K; Koller M; Ehinger C; Aggarwal N; Ashani Y; Goldsmith M; Sussman JL; Tawfik DS; Thiermann H; Worek F
    Toxicol Lett; 2016 Sep; 258():198-206. PubMed ID: 27397758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.